• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Novartis loses another NIBR exec as neuro expert Shanker joins a gene therapy biotech

Quote
cafead

cafead

Administrator
Staff member
  • cafead   May 19, 2021 at 10:32: AM
via Novartis' Gopi Shanker, Ph.D., is the latest R&D leader to exit the Swiss pharma giant as he takes up the helm of chief scientific officer at gene therapy startup Tevard Biosciences.

article source
 




Top Bottom
Back
Quote